FDA to Launch Next Generation CTP Portal Next Year

Regulations by 2FIRSTS.ai
Jul.16.2024
FDA to Launch Next Generation CTP Portal Next Year
FDA to launch new CTP portal for tobacco product applications next year, streamlining submission process for SE and PMTA reports.

On July 15th, the Center for Tobacco Products (CTP) of the US Food and Drug Administration (FDA) published two notices in the Federal Register, stating their plans to launch a new generation CTP web portal next year for the submission of certain new tobacco product applications.


The purpose of this improvement is:


Integration of major Substantial Equivalence (SE) reports and Premarket Tobacco Product Applications (PMTAs), previously submitted amendments, and general correspondence into one system; introducing a more efficient submission process by eliminating the need for multiple tools (including consolidating PDF editing software, FDA's eSubmitter desktop tool, and FDA's CTP Portal web application into one place); providing tools to expedite data entry, guide applicants to relevant sections, and verify that all necessary data has been provided. No action is required for current users of any CTP system for these improvements in the works. Existing CTP Portal accounts and any pending or ongoing applications will automatically migrate to the new CTP Portal Next Generation. CTP will provide additional communication and support before the changes take effect.


As part of submitting SE reports and PMTAs in the CTP Portal Next Generation, applicants will need to enter certain information on the applicable forms. Therefore, two Federal Register notices (one regarding SE, one regarding PMTA) announced today are seeking public input on entering this information.


The public comment period will begin on July 16 and end on September 14 at 11:59 PM (Eastern Time).


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Observation | Clear Tank E-Cigs Surge: Dedicated Coils Emerge as Supply Chain Best-Sellers
Observation | Clear Tank E-Cigs Surge: Dedicated Coils Emerge as Supply Chain Best-Sellers
At the e-cigarette supply chain expo held in Shenzhen on August 26, 2Firsts learned that dedicated coils for clear tank e-cigarettes have emerged as the top-selling products among suppliers.
Aug.26 by 2FIRSTS.ai
Sven Löhr Appointed as New Managing Director of British American Tobacco Austria GmbH, Plans to Lead Company's Smoke-Free Strategy to Reduce Smoking Rates in Austria to 5% by 2040
Sven Löhr Appointed as New Managing Director of British American Tobacco Austria GmbH, Plans to Lead Company's Smoke-Free Strategy to Reduce Smoking Rates in Austria to 5% by 2040
Sven Löhr appointed as new Managing Director of British American Tobacco Austria, focusing on smoke-free future and market leadership.
Sep.03 by 2FIRSTS.ai
BAT Executive: Company’s Smokeless Products Outperform Cigarettes in Japan and UK, Over 70% Share in Sweden
BAT Executive: Company’s Smokeless Products Outperform Cigarettes in Japan and UK, Over 70% Share in Sweden
James Murphy, Director of Research at British American Tobacco (BAT), said in a podcast that the company is accelerating its transition to smoke-free products, with sales in Japan and the UK already surpassing cigarettes, and a share of over 70% in Sweden.
Sep.01 by 2FIRSTS.ai
Company | Imperial Brands CEO: Expects double-digit NGP growth over the next five years; ZONE nicotine pouches reach ~3% share in the U.S.
Company | Imperial Brands CEO: Expects double-digit NGP growth over the next five years; ZONE nicotine pouches reach ~3% share in the U.S.
At the Barclays Global Consumer Staples Conference, the CEO of Imperial Brands outlined the company’s 2025–2030 strategy and direction for its Next-Generation Products (NGP). He said the NGP business has been “reset,” delivering double-digit growth over the past two years, with the aim of sustaining this pace for the next five years. In response to disposable-vape bans in the UK and France, the company has completed a pivot to rechargeable pod systems, doubling its UK market share and surpassing
Sep.12 by 2FIRSTS.ai
Research Brief | Current Use of Cigarettes, E-Cigarettes, and Cannabis Is Significantly Associated with Xerostomia
Research Brief | Current Use of Cigarettes, E-Cigarettes, and Cannabis Is Significantly Associated with Xerostomia
About 9.7% of 29,721 U.S. adults (18+) surveyed in 2022–2023 reported their mouth felt dry “frequently” or “always.” After multivariable adjustment, past-30-day use of cigarettes (AOR ≈ 1.52), e-cigarettes (≈ 1.46), or cannabis (≈ 1.57) was each linked to higher odds of xerostomia. Daily use showed stronger associations (cigarettes ≈ 1.67; e-cigarettes ≈ 1.80; cannabis ≈ 2.15). Concurrent use of all three products had the highest odds (AOR ≈ 3.80). The authors suggest dental professionals factor
Sep.12 by 2FIRSTS.ai
France Bans Oral Nicotine Products in Forms of Pouches, Pastes, Tablets, and Liquids Starting March 2026
France Bans Oral Nicotine Products in Forms of Pouches, Pastes, Tablets, and Liquids Starting March 2026
France's Decree No. 2025-898 bans all oral nicotine products nationwide six months after publication. Medicines and medical devices are exempt. This includes nicotine pouches, gum, lozenges, and other forms, regardless of origin. The decree is based on the Public Health Code and applies to mainland France and Wallis and Futuna Islands.
Sep.08